Acta Scientific Medical Sciences (ISSN: 2582-0931)

Review Article Volume 5 Issue 8

Neuroprotective Potential of Bioactive Sulfated Polysaccharides from Algae

Bitarka Bisai and Sirisha L Vavilala*

School of Biological Sciences, University of Mumbai, Kalina Campus, Mumbai, India

*Corresponding Author: Sirisha L Vavilala, Assistant Professor, School of Biological Sciences, University of Mumbai, Kalina Campus, Mumbai, India.

Received: June 28, 2021; Published: July 31, 2021

Citation: Bitarka Bisai and Sirisha L Vavilala. “Neuroprotective Potential of Bioactive Sulfated Polysaccharides from Algae". Acta Scientific Microbiology 5.8 (2021): 169-182.


Neurodegenerative diseases are disorders of the central nervous system and common cause of physiological and economic burden worldwide. Most of the current drugs for treatment of Parkinson’s Disease and Alzimer’s Disease aren’t sufficiently effective in preventing their progress and have multiple adverse side-effects. Hence, there is a need for therapeutics from natural sources. Interest for the use and exploitation of the marine algae is expanding. The marine environment is well known for its rich sources of chemical compounds with numerous beneficial health effects. It is known that many marine algae species contain Sulfated Polysaccharides (SPs) and their lower molecular weight oligosaccharide derivatives which are biocompatible, biodegradable and have been shown to offer numerous health benefits. This review highlights the different types of SPs from different algae, their structures, their bioactive potential particularly their immense potential for prevention of neurodegenerative diseases and provide a scientific basis to the development of new generation of phytopharmaceuticals which can be used alone or in combination with other drugs.

Keywords: Neurodegenerative Diseases; Natural Products; Sulfated Polysaccharides; Algae; Antioxidant Potential; Neuroprotective Agent


  1. Barbosa M., et al. “Bioactive Compounds from Macroalgae in the New Millennium: Implications for Neurodegenerative Diseases”. Marine Drugs 12 (2014): 4934-4972.
  2. Burns A and Iliffe S. “Clinical Review Alzheimer’s disease”. BMJ 338 (2009): 1-5.
  3. Sveinbjornsdottir S. “The clinical symptoms of Parkinson's disease”. Journal of Neurochemistry 1 (2016): 318-324.
  4. Bogaard S., et al. “MRI biomarkers in Huntington's disease”. Frontiers in Bioscience 4 (2012): 1910-1925.
  5. Seedevi V., et al. “A review on type 2 diabetes mellitus associated with cognitive dysfunction and dementia and future perspective”. World Journal of Pharmacy and Pharmaceutical Sciences 6 (2017): 579-600.
  6. Mukherjee A., et al. “Type 2 Diabetes as a Protein Misfolding Disease”. Trends in Molecular Medicine 21 (2015): 439-449.
  7. Dansette PM., et al. “Sulfur Containing Compounds as Antioxidants”. Advances in Experimental Medicine and Biology 264 (1990): 209-215.
  8. Schroeter H., et al. “MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide”. Neurobiology Aging 23 (2002): 861-880.
  9. Zhu X., et al. “The role of mitogen-activated protein kinase pathways in Alzheimer's disease”. Neurosignals 11 (2002): 270-281.
  10. Perry G., et al. “Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation”. Neuroreport 10 (1999): 2411-2415.
  11. Hensley K., et al. “p38 Kinase Is Activated in the Alzheimer’s Disease Brain”. Journal of Neurochemistry 72 (1999): 2053-2058.
  12. Munoz L and Ammit AJ. “Targeting p38 MAPK pathway for the treatment of Alzheimer's disease”. Neuropharmacology 58 (2010): 561-8.
  13. Borsello T and Forloni G. “JNK Signalling: A Possible Target to Prevent Neurodegeneration”. Current Pharmaceutical Design 13 (2017): 1875-1886.
  14. Yarza R., et al. “c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease”. Frontiers in Pharmacy 6 (2016): 321.
  15. Sandoval D., et al. “The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration”. Cell Signal 26 (2014): 2694-2701.
  16. Datta SR., et al. “Cellular survival: a play in three Akts”. Genes and Development 13 (1999): 2905-2927.
  17. Manigandan V., et al. “Marine carbohydrate-based therapeutics for Alzheimer's disease - mini review”. Journal of Neuroscience (2015).
  18. Gao Q-H., et al. “Neuroprotective effects of plant polysaccharides: A review of the mechanism”. International Journal of Biological Macromolecules (2017): S0141-8130 (17): 31360-0.
  19. Wei D., et al. “Synthesis, characterization, antioxidant activity and neuroprotective effects of Selenium polysaccharide from Radix hedysari”. Carbohydrate Polymer 125 (2015): 161-168.
  20. Xiang Q., et al. “Neuroprotective effects of Rhizoma Dioscoreae polysaccharides against neuronal apoptosis induced by in vitro hypoxia”. Experimental and Therapeutic Medicine 10 (2015): 2063-2070.
  21. Shao P., et al. “In vitro antioxidant and antitumor activities of different sulfated polysaccharides isolated from three algae”. International Journal of Biological Macromolecules 62 (2013): 155-161.
  22. Cunha L and Grenha A. “Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications”. Marine Drugs 14 (2016): 1-41.
  23. Souza RB., et al. “Neuroprotective effects of sulfated agaran from marine alga Gracilaria cornea in Rat 6- hydroxydopamine parkinson’s disease model: Behavioral, neurochemical and transcriptional alterations”. Basic and Clinical Pharmacology and Toxicology (2016).
  24. Patel S. “Therapeutic importance of sulfated polysaccharides from seaweeds: Updating the recent findings”. 3Biotech 2 (2012): 171-185.
  25. Na YS., et al. “Purification, characterization and immune stimulating activity of water-soluble polysaccharide isolated from Capsosiphon fulvescens”. International Immunopharmacology 10 (2010): 364-370.
  26. Costa LS., et al. “Biological activities of sulphated polysaccharides from tropical seaweeds”. Biomedicine and Pharmacotherapy 64 (2010): 21-28.
  27. Monteiro VS., et al. “Involvement of the GABAergic system in the anxiolytic effect of sulfated polysaccharides from the red seaweed Gracilaria cornea”. Journal of Applied Phycology 28 (2016): 1997-2004.
  28. Usov AI. “Structural analysis of red seaweed galactans of agar and carrageenan groups”. Food Hydrocolloids 12 (1998): 3301-3308.
  29. Jiao G., et al. “Chemical structures and bioactivities of sulfated polysaccharides from marine algae”. Marine Drugs2 (2011): 196-223.
  30. Jeon YJ., et al. “Characterization of agarose product from agar using DMSO”. Algae 20 (2005): 61-67.
  31. Percival E. “The polysaccharides of green, red and brown seaweeds: Their basic structure, biosynthesis and function”. British Phycological Journal 14 (2007): 103-117.
  32. Ruperez P., et al. “Biological activities of algal sulfated and non- sulfated polysaccharide”. In: (Eds Blanca Hernández-Ledesma, Miguel Herrero). Bioactive Compounds from Marine Foods: Plant and Animal Sources. John Wiley and Sons (2013).
  33. Wijesekara I., et al. “Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae”. Carbohydrate Polymers1 (2011): 14-21.
  34. Pangestuti R., et al. “Neuroprotective Effects of Marine Algae”. Marine Drugs 9 (2011): 803-818.
  35. Vadlapudi V. “Antioxidant activities of marine algae: a review”. In: Medicinal Plants as Antioxidant Agents: Understanding Their Mechanism of Action and Therapeutic Efficacy Research Signpost, edited by Capasso, A., 189-203. Kerala, India (2012).
  36. Raposo MFJ., et al. “Bioactivity and application of sulfated polysaccharides from marine microalgae”. Marine Drugs 11 (2013): 233-252.
  37. Chen B., et al. “Isolation and antioxidant property of the extracellular polysaccharide from Rhodella reticulata”. World Journal of Microbiology and Biotechnology 26 (2010): 833-840.
  38. Zhang Q., et al. “Antioxidant activities of sulfated polysaccharide fractions from Porphyra haitanesis”. Journal of Applied Phycology 15 (2003): 305-310.
  39. Yang JI., et al. “Aqueous extracts of the edible Gracilaria tenuistipitata are protective against H₂O₂-induced DNA damage, growth inhibition, and cell cycle arrest”. Molecules 6 (2012): 7241-7254.
  40. Ma X-T., et al. “Effect of Content of Sulfate Groups in Seaweed Polysaccharides on Antioxidant Activity and Repair Effect of Subcellular Organelles in Injured HK-2 Cells”. Oxidative Medicine and Cellular Longevity (2017).
  41. Lee JC., et al. “Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties”. Cancer Cell International 13 (2013): 55.
  42. Rocha de Souza MC., et al. “Antioxidant activities of sulfated polysaccharides from brown and red seaweeds”. Journal of Applied Phycology2 (2007): 153-160.
  43. Shao P., et al. “In vitro antioxidant and antitumor activities of different sulfated polysaccharides isolated from three algae”. International Journal of Biological Macromolecules 62 (2013): 155-161.
  44. Qi H., et al. “Antioxidant activity of different molecular weight sulfated polysaccharides from Ulva pertusa Kjellm (Chlorophyta)”. Journal of Applied Phycology 17 (2005): 527-534.
  45. Liu B and Hong JS. “Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention”. Journal of Pharmacology and Experimental Therapeutics 304 (2003): 1-7.
  46. Block ML., et al. “Microglia-mediated neurotoxicity: uncovering the molecular mechanisms”. Nature Reviews Neuroscience 8 (2007): 57-69.
  47. Lull ME and Block ML. “Microglial activation and chronic neurodegeneration”. Neurotherapeutics 4 (2010): 354-365.
  48. Abad MJ., et al. “Natural marine anti-inflammatory products”. Mini-Reviews in Medicinal Chemistry 8 (2008): 740-754.
  49. Cui YQ., et al. “Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia”. Clinical and Experimental Pharmacology and Physiology4 (2010): 422-428.
  50. Heales SJ., et al. “Nitric oxide, mitochondria and neurological disease”. Biochimica et Biophysica Acta 1 (1999): 215-228.
  51. Bartus RT. “On neurodegenerative diseases, models, and treatment strategies”. Experimental Neurology2 (2010): 495-529.
  52. Yoon NY., et al. “Phlorotannins from Ishige okamurae and their acetyl- and butyrylcholinesterase inhibitory effects”. Journal of Functional Foods 1 (2009): 331-335.
  53. Cowan CM., et al. “Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons”. Journal of Neuroscience 21 (2001): 7099-7109.
  54. Luo M., et al. “Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy”. Scientific Report 5 (2015): 11062.
  55. Fallarero A., et al. “Effects of the aqueous extract of Bryothamnion triquetrum on chemical hypoxia and aglycemia-induced damage in GT1-7 mouse hypothalamic immortalized cells”. Phytomedicine 13 (2006): 240-245.
  56. Jin D-Q., et al. “Ulva conglobata, a marine alga, has neuroprotective and anti-inflammatory effects in murine hippocampal and microglial cells”. Neuroscience Letter 402 (2006): 154-158.
  57. Robic A., et al. “Structure and interactions of ulvan in the cell wall of the marine green algae Ulva rotundata (Ulvales, Chlorophyta)”. Carbohydrate Polymer 77 (2009): 206-216.
  58. Blinkova LP., et al. “Biological activity of Spirulina”. Zhurnal Mikrobiologii, Epidemiologii, I Immunobiologii 2 (2001): 114-118.
  59. Fujitani N., et al. “Inhibitory effects of microalgae on the activation of hyaluronidase”. Journal of Applied Phycology 13 (2001): 489-492.
  60. Guzman S., et al. “Anti-inflammatory, analgesic and free radical scavenging activities of the marine microalgae Chlorella stigmatophora and Phaeodactylum tricornutum”. Phytotherapy Research 15 (2001): 224-230.
  61. Pulz O and Gross W. “Valuable products from biotechnology of microalgae”. Applied Microbiology and Biotechnology 6 (2004): 635-648.
  62. Stirk WA and van Staden J. “Comparison of Cytokinin-and Auxin-Like Activity in Some Commercially Used Seaweed Extracts”. Journal of Applied Phycology 8 (1997): 503-508.

Copyright: © 2021 Bitarka Bisai and Sirisha L Vavilala. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US